Correction: Andrographolide inhibits breast cancer through suppressing COX-2 expression and angiogenesis via inactivation of p300 signaling and VEGF pathway

J Exp Clin Cancer Res. 2023 Sep 16;42(1):241. doi: 10.1186/s13046-023-02818-7.

Yulin Peng^#¹, Yan Wang^#¹, Ning Tang^#^{1

2}, Dongdong Sun¹, Yulong Lan¹, Zhenlong Yu^{1

3}, Xinyu Zhao¹, Lei Feng^{1

3}, Baojing Zhang¹, Lingling Jin¹, Fabiao Yu³, Xiaochi Ma^{4

5}, Chuanzhu Lv⁶

¹ Institute of Integrative Medicine, College of Pharmacy, College of Basic Medical Science, Dalian Medical University, Dalian, 116044, China.
² Department of Integrative Medicine, Liaoning University of Traditional Chinese Medicine Xinglin College, Shenyang, 110167, China.
³ Emergency Department, The Second Affiliated Hospital of Hainan Medical University, Haikou, 571199, China.
⁴ Institute of Integrative Medicine, College of Pharmacy, College of Basic Medical Science, Dalian Medical University, Dalian, 116044, China. maxc1978@163.com.
⁵ Emergency Department, The Second Affiliated Hospital of Hainan Medical University, Haikou, 571199, China. maxc1978@163.com.
⁶ Emergency Department, The Second Affiliated Hospital of Hainan Medical University, Haikou, 571199, China. lvchuanzhu677@126.com.

^# Contributed equally.

No abstract available

Publication types